Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease.
- Author:
Hye Won LEE
1
;
Soo Jung PARK
;
Seong Ran JEON
;
Byong Duk YE
;
Jae Jun PARK
;
Jae Hee CHEON
;
Tae Il KIM
;
Won Ho KIM
Author Information
- Publication Type:Original Article
- Keywords: Inflammatory bowel diseases; Crohn disease; Colitis, ulcerative; Benign stricture; Balloon dilation
- MeSH: Colitis, Ulcerative; Constriction, Pathologic*; Crohn Disease; Follow-Up Studies; Hospitals, University; Humans; Inflammatory Bowel Diseases*; Male; Prognosis; Recurrence; Referral and Consultation; Retrospective Studies
- From:Gut and Liver 2018;12(5):530-536
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: Benign intestinal strictures are common complications in patients with inflammatory bowel disease (IBD). This study aimed to assess the long-term prognosis of endoscopic balloon dilation (EBD) to treat benign strictures in IBD patients. METHODS: Patients with IBD who had benign strictures and who underwent EBD in four tertiary referral university hospitals between January 2004 and February 2014 were retrospectively reviewed. Technical success was defined as the ability to pass the scope through the stricture after balloon dilation, and clinical success was defined as improved obstructive symptoms. RESULTS: Forty-two benign strictures were identified in 30 patients (15 males and 15 females). Technical success was achieved in 26 patients (86.7%) at the first EBD attempt and in all 30 patients (100%) at the second EBD attempt. Clinical success was seen in 28 patients (93.3%). The median follow-up duration was 134.8 months (range, 10.2 to 252.0 months), and recurrence occurred in eight patients (26.7%), who required repeat EBD. The median duration to relapse was 1.7 months (range, 0.2 to 6.3 months). During repeat EBD, perforation occurred in two cases (6.7%), which were both clipped successfully. Finally, only one patient (3.3%) underwent surgery for the relief of recurrent obstructive symptoms during the follow-up period. CONCLUSIONS: The experience of 10 years shows that EBD is safe and effective for the treatment of benign strictures in IBD patients. Importantly, EBD may allow long-term effective palliation of the symptoms associated with benign intestinal strictures in IBD patients.
